OPR - Delayed Quote • USD CRSP Jun 2024 80.000 put (CRSP240621P00080000) Follow 23.40 0.00 (0.00%) At close: April 17 at 12:03 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for CRSP240621P00080000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: CRSP CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years 3 Magnificent Stocks That Could Double or More by 2030 Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
